Influence of PAH Genotype on Sapropterin Response in PKU: Results of a Single-Center Cohort Study

Objective: Identifying phenylalanine hydroxylase (PAH) mutations associated with sapropterin response in phenylketonuria (PKU) would be an advantageous means to determine clinical benefit to sapropterin therapy. Methods: Sapropterin response, defined as a ≥30 % reduction in phenylalanine (Phe) level...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Leuders, Sarah, Wolfgart, Eva, Ott, Torsten, du Moulin, Marcel, van Teeffelen-Heithoff, Agnes, Vogelpohl, Lydia, Och, Ulrike, Marquardt, Thorsten, Weglage, Josef, Feldmann, Reinhold, Rutsch, Frank
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4110336/
https://ncbi.nlm.nih.gov/pubmed/24190797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2013_263
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia